Ocular Therapeutix: Why SOL-1 Trial Outcome Is Likely Positive

1) the active drug substance Axitinib, which used to belong to Pfizer, is an FDA-approved, oral, potent VEGFR inhibitor. So ...
Seeking Alpha

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment ...

Injection-free subgroup results demonstrated that a single intravitreal dose of 4D-150 without any supplemental anti-VEGF injections resulted in stable mean visual acuity that was equal to or higher ...
Antelope Valley Press

5 things to know about AMD that could save your vision

Age-related macular degeneration (AMD) once meant a slow, irreversible loss of vision, and many people still believe that's ...
News Medical

Oraya therapy is effective in maintaining vision with reduced injections for wet AMD patients

Oraya Therapeutics Inc. announced today that leading ophthalmologists from three European countries presented patient results following one year after a single treatment with Oraya Therapy for wet age ...
Cambridge Network

Gene therapies for wet AMD: reshaping the blockbuster anti‑VEGF market

Wet age-related macular degeneration (wet AMD) is a progressive eye disease in which abnormal, fragile blood vessels grow under the macula and leak fluid or blood, leading to irreversible central ...

Innovative treatments are improving outcomes for thousands with sight-threatening eye disease - local clinic supports AMD Awareness Month

Latest treatments for Age-related Macular Degeneration (AMD) are giving hope to thousands of people living with the condition.